benactyzine has been researched along with Parkinson Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HIMWICH, HE; RINALDI, F | 1 |
| NATHAN, PW | 1 |
| Kamenetskiĭ, VK | 3 |
| Kamenetskiĭ, VK; Losev, NA | 1 |
1 trial(s) available for benactyzine and Parkinson Disease
| Article | Year |
|---|---|
[Experience with amysil treatment of patients with vascular parkinsonism].
Topics: Adult; Aged; Antiparkinson Agents; Benactyzine; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Parkinson Disease | 1989 |
5 other study(ies) available for benactyzine and Parkinson Disease
| Article | Year |
|---|---|
The antiparkinson activity of benactyzine.
Topics: Benactyzine; Humans; Parkinson Disease; Tranquilizing Agents | 1957 |
Benactyzine in patients with violent tempers and patients with Parkinsonism.
Topics: Aggression; Behavior; Benactyzine; Etoposide; Humans; Parasympatholytics; Parkinson Disease; Parkinsonian Disorders; Tranquilizing Agents | 1958 |
[Combined use of metamizil and midantan in vascular parkinsonism].
Topics: Aged; Amantadine; Benactyzine; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Humans; Middle Aged; Parkinson Disease; Tablets | 1979 |
[Combined administration of cholinolytic metamizil and L-Dopa in vascular parkinsonism].
Topics: Aged; Benactyzine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Vascular Diseases | 1978 |
[Method of treating parkinsonism with metamizil in combination with galanthamine (clinico-experimental basis)].
Topics: Aged; Animals; Benactyzine; Brain; Drug Therapy, Combination; Galantamine; Humans; Male; Mice; Middle Aged; Parkinson Disease; Receptors, Muscarinic; Receptors, Nicotinic | 1985 |